Soluble guanylate cyclase: an old therapeutic target re-visited.
about
NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potentialChronic Activation of Heme Free Guanylate Cyclase Leads to Renal Protection in Dahl Salt-Sensitive Rats.Phospholemman Ser69 phosphorylation contributes to sildenafil-induced cardioprotection against reperfusion injury.A Rho-kinase inhibitor, soluble guanylate cyclase activator and nitric oxide-releasing PDE5 inhibitor: novel approaches to erectile dysfunction.Role of cyclic GMP on inhibition by nitric oxide donors of human eosinophil chemotaxis in vitro.Current and future trends in the oral pharmacotherapy of male erectile dysfunction.Cinaciguat, a soluble guanylate cyclase activator, augments cGMP after oxidative stress and causes pulmonary vasodilation in neonatal pulmonary hypertension.Antiinflammatory activity of soluble guanylate cyclase: cGMP-dependent down-regulation of P-selectin expression and leukocyte recruitment.Update in pulmonary hypertension 2005.The future of the oral pharmacotherapy of male erectile dysfunction: things to come.Novel therapies for cyclic GMP control of vascular smooth muscle growthCinaciguat, a soluble guanylate cyclase activator, causes potent and sustained pulmonary vasodilation in the ovine fetus.Crystal structure of an oxygen-binding heme domain related to soluble guanylate cyclases.Is Nitric Oxide (NO) the Last Word in Radiosensitization? A Review.Design of fluorescence resonance energy transfer (FRET)-based cGMP indicators: a systematic approachIdentification of residues crucially involved in the binding of the heme moiety of soluble guanylate cyclase.Intraplatelet cyclic guanosine-3',5'-monophosphate levels during pregnancy and preeclampsia.
P2860
Q24656131-7BBF7A1A-5265-4E38-9F62-947503C44286Q30315850-E5F14081-711C-47E1-9AC3-507A53467434Q34150566-81B9673B-2773-43F9-AE95-F106CD08C731Q35001011-EF906446-F208-4295-8D53-DF47AFAE3506Q35046172-0C1554A0-870E-48F9-90C5-ACE401D40B36Q35207625-D0881D0C-8554-4367-9DFF-EC19230A3CA4Q35543584-444F3406-5077-4343-815B-E6C734980C59Q36018283-8093E247-1A46-4BB7-8D74-434C8DB69CCFQ36403168-E77A4F23-F482-4E89-A70B-9EDB32A55FEAQ36866594-F77BEC67-845A-4BA3-B48C-FCF42499AC3DQ37179695-4C1BBAC7-56E3-46FD-BDD9-D82774F3B9FBQ37343908-237AE515-4495-4596-B32A-27CF183F9538Q37511692-EFD62D1D-41F4-4D09-8ECF-82FA48098D88Q38002028-AF25C06A-CEF1-4BE0-8523-DDCE7438074FQ41765778-FE495316-9C6E-4E04-8325-3D616A0FEE0FQ44626758-0220AE67-7A00-4AED-A3B7-28C5D51B4E8EQ45200154-35B80AE0-20C8-40BA-BB71-2586B826B2A4
P2860
Soluble guanylate cyclase: an old therapeutic target re-visited.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Soluble guanylate cyclase: an old therapeutic target re-visited.
@en
Soluble guanylate cyclase: an old therapeutic target re-visited.
@nl
type
label
Soluble guanylate cyclase: an old therapeutic target re-visited.
@en
Soluble guanylate cyclase: an old therapeutic target re-visited.
@nl
prefLabel
Soluble guanylate cyclase: an old therapeutic target re-visited.
@en
Soluble guanylate cyclase: an old therapeutic target re-visited.
@nl
P2860
P356
P1476
Soluble guanylate cyclase: an old therapeutic target re-visited
@en
P2093
Adrian J Hobbs
P2860
P304
P356
10.1038/SJ.BJP.0704779
P407
P577
2002-07-01T00:00:00Z